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ABSTRACT
Cholinergic human brain currents were recorded in Xenopus laevis oocytes
transplanted with human cerebral membranes from two different zones, the frontal
cortex and the hippocampus. The recorded currents were supported by the nicotinic
or the muscarinic acetylcholine receptor. We tested the effects of a number of
several nicotinic agonists acetylcholine, nicotine and 1,1-dimethyl-4-phenyl-
piperazinium iodide (DMPP), and the nicotinic receptor antagonists a-bungarotoxin
and d-tubocurarine on the transplanted oocytes. We detected four kinds of nicotinic
current kinetics. The differences in the amplitude and in the total electric charge
of the currents elicited by various agonists at a range of holding potentials were
not significant, except in the case of DMPP at a holding potential of -90 mV. Our
results indicate that α4β2, α3β4 and α7 are the main nicotinic receptors in human
brain.
Key words: Human cortex.—Neuronal nicotinic currents.—Xenopus oocytes.—
Membrane transplant.—Alzheimer.—Brain bank.
RESUMEN
Corrientes colinérgicas en oocitos de Xenopus trasplantados
con membranas de cerebro humano
Corrientes colinérgicas de cerebro humano fueron registradas en oocitos de
Xenopus laevis trasplantados con membranas de cerebro humano procedentes de
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dos zonas diferentes, la corteza frontal y el hipocampo. Las corrientes registradas
fueron activadas por el receptor nicotínico o por el receptor nicotínico o musca-
rínico de la acetilcolina. Se probaron los efectos de diferentes agonistas nicotínicos
como acetilcolina, nicotina y yoduro de 1,1-dimetil-4-fenil-piperazinio (DMPP), y
antagonistas del receptor nicotínico como a-bungarotoxina y d-tubocurarina en los
oocitos transplantados. Detectamos cuatro clases de cinéticas de corrientes nico-
tínicas. Las diferencias en la amplitud y en la carga eléctrica total de las corrientes
provocadas por varios agonistas en el rango de potencial mantenido no fueron
significativas, excepto en el caso del DMPP a un potencial mantenido de -90 mV.
Nuestros resultados indican que las formas α4β2, α3β4 y α7 son los principales
receptores nicotínicos en el cerebro humano.
Palabras clave: Córtex humano.—Corrientes nicotínicas neuronales.—Oocitos
de Xenopus.—Trasplante de membrana.—Alzheimer.—Banco de cerebros.
INTRODUCTION
The cholinergic pathways in the central nervous system play a
significant role in cognitive and behavioral functions such as
learning, memory, arousal, cerebral blood flow and metabolism.
Neuronal nicotinic and muscarinic receptors are involved in these
functions (1-3).
The neuronal nicotinic acetylcholine receptors are a family of
acetylcholine-gated ion channels which has been characterized
combining molecular cloning and pharmacology. Several subtypes
with a specific pharmacology, physiology and anatomical
distribution, have been found. A gene family encoding 11 of these
receptors, has been identified, and most of them have been cloned
and expressed in transfected cells (4). Two main subunits have been
documented: a and b chains. To date 8 types of α and 3 types of β
chains have been detected. Mutations in one of the subunit genes
account for some pathological conditions such as a specific form of
epilepsy or schizophrenia and in neurodegenerative illnesses, such
as Alzheimer’s and Parkinson’s disease, high affinity neuronal
nicotinic acetylcholine receptors sites are reduced (3).
Studies of recombinant neuronal nicotinic receptor expressed in
Xenopus oocytes show that coexpression of the α and β subunits is
needed to form an active receptor with a pentameric structure.
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However, expression systems α7, α8 and α9 result in active homo-
oligomeric receptors (3, 5). The expression of combinations of
distinct mRNA subunits in Xenopus oocytes shows the individual
pharmacological profiles of the subunit combinations and which
makes it possible to identify the type of nicotinic receptor according
to its profile (6). The specific combination of the types of subunits
determines the pharmacology of these receptors (7).
The presence of distinct subunits in human brain has been
established by in situ hybridization techniques, but we do not know
the combination of the subunits in each native receptor. In addition
functional activity, has been tested by expressing the mRNA encoding
subunits in Xenopus oocytes. Here we assessed the physiology of the
human neuronal nicotinic acetylcholine receptor by transplanting
membranes obtained from human brain into Xenopus oocytes. This
technique alowed us to study the pharmacology of native receptors
in their original lipid and proteic environment.
MATERIALS AND METHODS
1. Subcellular fractionation protocol in human brain
Frozen brain tissue was obtained from the «Banc de Teixits
Neurològics. Serveis Científico-Tècnics. Universitat de Barcelona.
Hospital Clínic», at 7 h post-mortem from a 66-year-old male donor
with no history of neurological disorder (reference BK360). The
samples were from the frontal cortex and hippocampus.
Subcellular fractionation was performed following the method
described by Blackstone et al. (8). All procedures were performed at
4º C. About 1 g of frozen brain was homogenized 10 times at 600
r.p.m. with a glass-teflon homogenizer (Potter S, B. Braun Biotech
International) in 10 volumes with a solution 4 mM HEPES, 1 mM
EDTA (pH 7.4) with 2 μg/ml leupeptin, 1mM phenyl-methylsulfonyl
fluoride (PMSF), 20 μg/ml aprotinin, 2.5 μg/ml pepstatin. The
homogenate was agitated for 30 min and centrifuged at 1000 g for
10 min. The supernatant was then centrifuged at 25000 g for 20 min.
The resulting sediment was resuspended in the solution plus 0.25 M
sucrose and layered onto a discontinuous sucrose gradient
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containing 0.8 M/1 M/1.2 M sucrose and centrifuged for 2 h at 65000
g in a Beckman SW-28 rotor. A synaptic membrane fraction was
yielded at the 1 M/1.2 M sucrose interface, myelin in the floating
fraction and a mitochondrial fraction as the pellet. The synaptic
plasma membrane fraction was diluted 1/3 in a solution HEPES 10
mM and centrifuged for 30 min at 50000 g. The resulting sediment
was resuspended in a HEPES 10 mM, KCl 140 mM (pH 7.4) solution,
frozen with liquid nitrogen and stored at –80 ºC until use.
2. Animals and solutions
Mature females of Xenopus laevis were purchased from the «Centre
d’Elevage des Xenopes» (Montpellier, France), and were anaesthetized
by immersion in water containing 0.17 % tricaine. A few lobes were
removed from an ovary through a small incision in the abdomen.
Solutions for Xenopus oocytes: Barth’s solution contained: 88 mM
NaCl, 1 mM KCl, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4,
2.40 mM NaHCO3, and 20 mM HEPES at pH 7.4, supplemented with
100 IU/ml penicillin and 0.1 mg/ml streptomycin. Recording solution:
115 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, and 10 mM HEPES at pH
7.4. None of the Xenopus female donors used in this study exhibited
muscarinic acetylcholine receptor currents in their oocytes.
3. Oocyte preparation, membrane transplantation
and recording
Oocytes at stages V and VI (9) were removed out and kept at 15-
16º C in sterile Barth’s solution. Healthy oocytes were microinjected
with volumes within 50-100 nl of thawed suspension of human brain
membranes (3-10 mg/ml) following Marsal et al. (10), by means of an
injector (WPI, model A203XVZ). Samples were sonicated prior to
injection.
Before recording (3-4 h), oocytes were treated with collagenase
type 1A (Sigma) (0.5 mg/ml) for 45-50 min at room temperature to
remove the surrounding layers (11). They were then voltage-clamped
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with a two-electrode system (Axoclamp-2A, Axon Instruments, USA)
20-48 h after the membrane transplant. Intracellular electrodes (1-3
MW resistance) were filled with 3 M KCl for voltage recording and
current injection. The volume of the oocyte recording chamber was
200 µl. Membrane currents were sampled by Lab PC+ (National
Instruments, USA) at twice the filter frequency, low-pass filtered
at 10 Hz and recorded on a PC using the Whole Cell Analysis v. 2.1.
program which was kindly provided by Prof. J. Dempster
(Strathclyde University, Scotland, UK). Currents were elicited by
challenges of 1-3 mM cholinergic agonist. The interval between
consecutive responses was systematically set to 10-12 min (flow
rate 6-8 ml. min–1), as we had previously established that this
was sufficient to ensure a complete recovery from receptor
desensitization. Oocytes from Xenopus donors were tested for
muscarinic acetylcholine receptors. To ensure the consistency of the
response amplitude, three consecutive agonist challenges were
applied before changing to other agonist or antagonist.
We tested the effects of the nicotinic agonists, nicotine,
acetylcholine, 1,1-dimethyl-4-phenyl-piperazinium iodide (DMPP), at
concentrations from 1 to 3 mM, on the Xenopus oocytes transplanted
with the human brain membranes. The membranes from frontal
cortex were obtained in two independent fractionations. The results
were recorded in oocytes from 12 Xenopus donors.
4. Measurement and calculations
The amplitude and time constant of responses was measured
through Whole Cell Analysis. Statistical analysis was done using
SigmaStat 2.0 (SPSS Inc, Chicago, IL), using the one way Anova
Test.
5. Drugs
(-)-Nicotine, acetylcholine chloride, 1,1-dimethyl-4-phenyl-
piperazinium iodide (DMPP), α-bungarotoxin and d-tubocurarine
chloride were obtained from Sigma, St Louis, MO, USA.
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RESULTS
Transplant of human brain membranes, either from cortex or
hippocampus, into Xenopus oocytes significantly decreased the
oocyte resistance (p < 0.05); (0.3 ± 0.05 MΩ) (n = 16) vs (0.8 ±
0.2 MΩ) (n = 12) in oocytes injected with H2O. Usually, after 20-
48 h of membrane injection, we recorded an inward current in
response to cholinergic agonists in 30-40% of the injected oocytes.
When acetylcholine was used some of the responses (between
40-50% of the oocytes tested) were from the muscarinic receptor
(Fig. 1a) because the response was of the oscillatory type and
remained active for several minutes and was sensitive to atropine
(Fig. 1b). In other oocytes we found a non-oscillatory response after
perfusing with the nicotinic agonists acetylcholine, or nicotine or
DMPP.
We found four kinds of nicotinic currents depending on
the agonist applied, Figs. 1 C, D, E, F. In the first kind of response
(Fig. 1 C) the current opened fast (τ = 6.9 ± 2.2 s) and was maintained
while perfused with the agonist. This kind of current, which was
not so usual (8/83 responses) was observed using acetylcholine
(7/8 responses) and nicotine (1/8 responses) but not with DMPP.
The second kind of current (Fig. 1 D), the most common (53/83
responses) opened slowly (τ = 19.7 ± 4.7 s) and increased until the
agonist was washed out (in some cases, we exposed the oocyte to
the agonist for 90 s and the inward current increased at a constant
rate throughout exposure. A third kind of response (Fig. 1 E, 17/83
responses) exhibited dual kinetics: it started as a fast opening
(τ = 8.12 ± 1.4) but then slowed down until the agonist was washed
out (τ = 16.2 ± 1.7). Finally, we identified a fourth kind of current
(Fig. 1 F) that opened with a τ = 6.4 ± 0.8 s and closed spontaneously
before the agonist was washed out. This kind of current was not
usual (5/83 responses) and was observed only using DMPP (4/5) and
nicotine (1/5).
The total recording time in one oocyte varied from 40 to 90 s.
Table 1 summarizes the amplitude of responses obtained at a range
of holding potentials, –80, –90, –100 mV. In each holding potential
group, the amplitude of the currents was independent of the agonist
used, except in the case of DMPP when was measured at –90 mV.
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When the membranes were obtained from oocytes injected with
hippocampus membranes, we found the same results as described in
cerebral cortex, except that no differences between the agonist were
detected.
FIGURE 1. Effects of nicotinic agonists on the size of the currents at a holding po-
tential of –90 mV with an exposure of 40 s. In this case the membranes were from
frontal cortex. (A) Muscarinic current induced by 3mM acetylcholine. (B) Muscarinic
current inhibited by 0.5 mM atropine. (Current obtained in the same oocyte as point
A). (C) Nicotinic current induced by 3 mM acetylcholine. (D) Nicotinic current indu-
ced by 3 mM nicotine. (E) Nicotinic current induced by 3 mM DMPP. (F) Nicotinic
current induced by 3 mM DMPP, note that in this case the channel closed before the
end of exposure to the agonist.
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TABLE 1. Effects of a range of concentrations of agonist at distinct membrane
potentials on the size of the induced currents
Amplitude (nA) Charge (nQ) n
[agonist] (time exposure) at –100mV
1 mM acetylcholine (40 s) FC 29.5 ± 4.5 440 ± 223 8
1 mM nicotine (40 s) FC 33.8 ± 4.7 736 ± 106 6
1 mM DMPP (40 s) FC 33 ± 4 812 ± 215 5
[agonist] (time exposure) at –90mV
3mM acetylcholine (40 s) FC 18 ± 2.5 a 418 ± 83 a 5
3mM nicotine (40 s) FC 25 ± 5 a 584 ± 138 a 6
3mM DMPP (40 s) FC 47 ± 10a,b 1094 ± 206a,b 6
[agonist] (time exposure) at –80mV
3mM acetylcholine (30 s) FC 8 ± 5 113.5 ± 78.5 2
3mM nicotine (30 s) FC 15 ± 2 271 ± 79 4
3mM DMPP (30 s) FC 15 ± 4b 295 ± 142,b 4
[agonist] (time exposure) at –90mV
3mM acetylcholine (30 s) H 24 ± 10 207 ± 28 3
3mM nicotine (30 s) H 23 ± 2 522 ± 79 3
3mM DMPP (30 s) H 22 ± 6 253 ± 103 2
FC = frontal cortex, H=hippocampus.
The values are in amplitude nA and in nQ area, total surface under the profile of
the current. Results are presented as mean ± S.E.M, differences between valuesa and
between valuesb were significant p < 0.05.
The nicotinic antagonists, α-bungarotoxin (10 nM) and d-tubo-
curarine chloride (10 μM), had an inhibitory effect on the currents
reducing their size (Fig. 2 and Table 2). Both α-bungarotoxin and
d-tubocurarine antagonize the effect of acetylcholine, nicotine and
DMPP.
VOL. 71 (4), 821-833, 2005 CHOLINERGIC CURRENTS IN XENOPUS...
829
FIGURE 2. Effects of nicotinic antagonists on the currents induced by nicotinic
agonists. (A) Current induced by 3 mM DMPP. (B) Current induced by 3 mM DMPP
with the presence of d-tubocurarine (10 μM) 1 min before the exposure to DMPP and
during this exposure. (C) Current induced by 3 mM nicotine. (D) Current induced
by 3 mM nicotine with the presence of α-bungarotoxin (10 nM) 1 min before the
 exposure to nicotine and during exposure.
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TABLE 2. Effects of the aplication of antagonists in the presence of agonists.
Results are in % of inhibition
Agonist / agonist+antagonist Amplitude (% inhib.)
FRONTAL CORTEX
nicotine/nicotine+d-tubocurarine 42 ± 4 n = 8
DMPP/DMPP+a-bungarotoxin 42 ± 4 n = 3
DMPP/DMPP+d-tubocurarine 43 ± 1 n = 3
HIPPOCAMPUS
acetylcholine/acetylcholine+d-tubocurarine 29 n = 1
Nicotine/nicotine+d-tubocurarine 26 ± 2 n = 2
d-tubocurarine was at a concentration of 10 μM and α-bungarotoxin at a concen-
tration of 10 nM
DISCUSSION
In the human brain most high affinity neuronal nicotinic
acetylcholine receptors seem to comprise an arrangement of α4β2
subunits. Combinations with α3 subunits and homomeric α7
constitute the other major part. However various combinations of
α2, α3, α5, α6 and β2 and β4 subunits are also coexpressed to form
heteromeric receptors (3, 12-14).
In previous studies that have involved injecting human mRNA
to Xenopus oocytes, recombinant human neuronal nicotinic
acetylcholine receptors displayed differential sensitivity to nicotinic
agonists and antagonists and distinct kinetics, depending on the
subunit combinations and on the concentration of agonist used. The
sensitivity to the antagonists also differed depending on combination
of the subunits present in the receptor (3, 6).
We must point out that native human nicotinic acetylcholine
receptors are still active 7 hours after death, the brain extraction and
even after freezing and thawing. Here we recorded small currents
by perfusing acetylcholine over oocytes transplanted with human
brain membranes. The small amplitude of the currents may be
due to: a small number of receptors incorporated into the Xenopus
oocyte or to the poorly represented nicotinic receptors in the zones
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of human brain where membranes were obtained (3). In some cases,
using acetylcholine, we recorded currents from human muscarinic
receptors with the characteristic oscillatory profile for several
minutes because this profile was caused by fluctuations in
intracellular IP4 which led the opening of calcium activated chloride
channels (15).
The oocytes in which were stimulated by all the agonists tested
were taken as the most representative, with respect to sensitivity to
the agonists. Generally, we recorded differences in the effect of these
agonists in the same oocyte but did not find any significant difference
between the means. However, with DMPP at a holding potential of
–90 mV, the difference was significant and may be due to a greater
incorporation of α7 or α3β4 receptors, in which DMPP is the most
potent agonist (6).
The distinct kinetics of the currents detected can be explained by
the predominant presence of some subunit combinations and to the
concentration of the agonist dose used. Currents elicited in α3β4 and
α3β2 decay substantially faster than those recorded in α2β4 or α4β4,
and the currents elicited by the α7 receptor are faster that any other
heteromeric combination (6). The currents that we recorded could
be the addition of the distinct kinds of receptor currents, in which,
in some cases, the prevalence of one of the receptors determines the
profile or the kinetics of the current. We found that sensitivity to a-
bungarotoxin was about 40%, a result which indicated the presence
of the human neuronal nicotinic acetylcholine receptor α7 in the
sample, the only neuronal subunit with sensitivity to a-bungarotoxin.
Sensitivity to d-tubocurarine was variable, with mean inhibition
between 26% and 43% of the current induced by the agonist,
depending on the brain zone from where membranes were obtained.
These results indicate the major presence of α4β2 and α7 subunits
in the frontal cortex sample, because these receptors are sensitive
to d-tubocurarine of 50% (6). In the currents obtained from
hippocampus this inhibition was lower.
In conclusion, active nicotinic receptors survive for at least several
hours after death. The profiles of the currents of transplanted human
brain nicotinic receptors are very similar to those recorded from
oocytes expressing human mRNA, indicating that the latter model is
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similar to the actual currents in human brain, and not merely a
chimeric combination of different receptor subunits. Our results,
therefore reinforce the usefulness of Xenopus oocytes expressing
human nicotinic mRNA as a tool for pharmacological research to
design drugs to ameliorate the symptoms in Alzheimer patients. The
pharmacology of the nicotinic current recorded reveals that the main
native combination of subunits corresponds to α4β2, α3β4 and α7
receptors which is consistent with the major presence of nicotinic
receptors in human brain (12-14).
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